US FDA Launches Program to Boost Domestic Drug Manufacturing

FDA Launches PreCheck Pilot Program to Bolster Domestic Drug Manufacturing

The PreCheck pilot program is designed to strengthen the US pharmaceutical supply chain by increasing regulatory predictability and streamlining the assessment of new domestic manufacturing sites.

FDA Moves To Bring Pharma Manufacturing Back To US With New Pilot - Eli Lilly and Co (NYSE:LLY)

The U.S. Food and Drug Administration (FDA) on Sunday opened applications for its FDA PreCheck pilot program, aimed at strengthening the domestic pharmaceutical supply chain by improving regulatory predictability, supporting the build-out of U.S. manufacturing sites, and streamlining facility assessments ahead of drug applications. FDA Commissioner Marty Makary said the initiative is part of broader efforts to reverse decades of offshore drug ma…

FDA launches pilot programme to boost US manufacturing

The FDA has started accepting requests to participate in its PreCheck pilot programme, promising rapid reviews of new manufacturing facilities

FDA opens fast-track program to speed U.S. drug plant construction

US FDA launches program to boost domestic drug manufacturing

The U.S. Food and Drug Administration on Sunday began accepting requests to participate in its PreCheck pilot program, designed to boost domestic drug supply by speeding up construction and review of drug manufacturing plants in the country.

FDA launches program to boost domestic drug manufacturing

WASHINGTON – The U.S. Food and Drug Administration on Sunday began accepting requests to participate in its PreCheck pilot program, designed to boost domestic drug supply by speeding up construction and review of drug manufacturing plants in the country.